News and Announcements
Stop Chasing VCs, Go After Angel Investors Instead
- Published December 14, 2022 6:31AM UTC
- Publisher Osama Hassan
- Categories Capital Raising Tips
Most first-time founders automatically think that VCs are where it’s at. The crucial thing about venture, though, is the investment criteria.
VCs are only interested in the tiniest minority of ideas. In some ways, it doesn’t actually matter how likely you are to succeed. If your startup doesn’t tick the “power law” box (the law states that the vast majority of returns come from a tiny minority of deals), there’s almost no chance a VC will invest in you, even if your business is a sure thing.
Most founders waste far too much time chasing VCs, when they’d be far better speaking with angel investors and family offices. Granted, they’re harder to find, but they’re also more likely to invest. For VCs, there’s no such thing as medium success. For them, an investment is either a game changer or it’s a statistic.
🙌
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
